Evaluation of dynamic thiol-disulfide homeostasis and ischemia-modified albumin levels in patients with chronic lymphocytic leukemia

Huseyin Erdal, Rafiye Ciftciler, Sibel Cigdem Tuncer, Oguzhan Özcan
DOI: 10.1136/jim-2022-002568 Published 29 August 2022

Article Information

DOI 
https://doi.org/10.1136/jim-2022-002568
PubMed 
36038148
Print ISSN 
1081-5589
Online ISSN 
1708-8267
History 
  • Accepted August 10, 2022
  • Published online August 29, 2022.
Copyright & Usage 
© American Federation for Medical Research 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Author Information

  1. Huseyin Erdal1,
  2. Rafiye Ciftciler2,
  3. Sibel Cigdem Tuncer3,
  4. Oguzhan Özcan4
  1. 1Medical Genetics, Aksaray University, Aksaray, Turkey
  2. 2Hematology, Aksaray University, Aksaray, Turkey
  3. 3Biochemistry, Aksaray University, Aksaray, Turkey
  4. 4Biochemistry, Hatay Mustafa Kemal University, Hatay, Turkey
  1. Correspondence to Dr Huseyin Erdal, Medical Genetics, Aksaray University, Aksaray, Merkez, Turkey; herdalyfa{at}gmail.com
View Full Text

Article usage

Article usage: August 2022 to May 2023

AbstractFullPdf
Aug 202212301418
Sep 2022420234
Oct 202214450
Nov 20228442
Dec 20229940
Jan 202312062
Feb 20232440
Mar 20232941
Apr 20232240
May 20232650

Statistics from Altmetric.com

Back to top
Email
Print
Alerts
Citation Tools
Cite This
Download PDF

Evaluation of dynamic thiol-disulfide homeostasis and ischemia-modified albumin levels in patients with chronic lymphocytic leukemia
Huseyin Erdal, Rafiye Ciftciler, Sibel Cigdem Tuncer, Oguzhan Özcan
Journal of Investigative Medicine Aug 2022, jim-2022-002568; DOI: 10.1136/jim-2022-002568
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article